Navigation Links
NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
Date:11/13/2008

ANN ARBOR, Mich., Nov. 13 /PRNewswire/ -- NanoBio Corporation announced today that it will present new data in four presentations that detail milestones in its clinical and preclinical development programs in onychomycosis, acne, herpes labialis and genital herpes during the American Association of Pharmaceutical Scientists (AAPS) meeting November 16-20, 2008 in Atlanta, GA.

The company's presentation schedule during the conference:

Tuesday, November 18, 1:00 PM - 5:00 PM

-- In-vitro Skin Permeation of Novel Antimicrobial Nanoemulsion

Formulations

-- Lateral Diffusion of a Novel Antifungal Nanoemulsion In-vitro Human

Cadaver Skin

-- Pharmacokinetics of a Novel Topical Antimicrobial Nanoemulsion

Wednesday, November 19, 1:00 - 5:00 PM

-- Long Term Stability of NB-001: A Novel Antiviral Nanoemulsion

These studies confirm the skin permeation, overall safety and long-term stability of nanoemulsion-based therapies. The data support the continued development of NanoBio treatments for a wide range of skin and mucosal infections, including NanoBio's lead products identified above as well as treatments for tinea capitis (ringworm), molluscum contagiosum (pox virus warts) and other topical fungal, bacterial and viral infections.

About NanoBio

NanoBio(R) Corp. is a privately held biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat(TM) technology platform. The company's lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fungus), acne, and a broad platform of mucosal vaccines. NanoBio has demonstrated robust efficacy and safety in randomized, double-blind, placebo-controlled phase 2a and phase 2b studies involving over 800 subjects with recurrent herpes labialis. A large phase 2 trial is nearing completion in onychomycosis and clinical trials are p
'/>"/>

SOURCE NanoBio Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NanoBio Expands Drug Development Team for Its Anti-Infective Products
2. Dr. Joyce Sutcliffe Joins the NanoBio Team as Vice President of Research
3. David M. Stout Joins NanoBio Corporations Board of Directors
4. FierceBiotech Names NanoBio Corporation as One of the Fierce 15 Biotech Companies of 2008
5. Daniel B. Dubin, M.D., Joins NanoBio Corp.s Board of Directors
6. NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008
7. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
8. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
9. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
10. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
11. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... (PRWEB) April 21, 2015 YourEncore, ... the life sciences, consumer products and food sciences ... and the Alliance for Clinical Research Excellence and ... system for conducting clinical research, have partnered to ... , YourEncore brings to ACRES experts ...
(Date:4/20/2015)... VANCOUVER, British Columbia and ...   DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... data at the 106th Annual Meeting of ... Annual Meeting on the potential for its lead ...
(Date:4/20/2015)... Orthobiologics are substances that are ... orthobiologics market is a rewarding market, which represents a ... orthobiologics market report defines and segments the concerned market ... market was valued at $5,712.4 million in 2014, and ... a CAGR of 6.7% from 2014 to 2019. ...
(Date:4/20/2015)... CITY, Calif. , April 20, 2015 ... InterpretOmics Pvt. Ltd. to provide an integrated Big Data ... of all biomarkers collected in the context of clinical ... needs of precise or multi-targeted drug candidates, stratified patient ... and disease progression free survival. Highlighting ...
Breaking Biology Technology:YourEncore and ACRES Partner to Drive Innovation in Clinical Research 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 2Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 3PointCross Life Sciences and InterpretOmics partner for Clinical and Genomic Biomarker Management for Drug Development 2
... of storing electronic information from old cassette tapes ... force in the electronics industry for decades. , Low-power, ... collaborative research led by Cornell materials scientist Darrell Schlom. ... journal Science (Vol. 324 No. 5925), involves ...
... Review Services to Improve Safety and Quality of ... a leading provider of specialty healthcare solutions, and ... been selected by the New York State Department ... best practice utilization review program. The program examines ...
... Proteolix, Inc. today announced the appointment of Craig C. ... and Corporate Development and Chief Financial Officer (CFO), and ... leadership team with the appointment of Michael G. Kauffman, ... (CMO) and Albert L. Kraus, Ph.D., to the newly-created ...
Cached Biology Technology:Putting the squeeze on an old material could lead to 'instant on' electronic memory 2APS Healthcare and Thomson Reuters to Manage New York State's Medicaid Clinical Best Practices Review Program 2APS Healthcare and Thomson Reuters to Manage New York State's Medicaid Clinical Best Practices Review Program 3APS Healthcare and Thomson Reuters to Manage New York State's Medicaid Clinical Best Practices Review Program 4Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team 2Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team 3Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team 4
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) ... Recognition Market in Automotive Sector 2014-2018" report to ... Gesture Recognition market in Automotive Sector to grow at ... Gesture recognition is the ability of a device ... individual. Gesture recognition technology can be 2D-based or 3D-based. ...
(Date:3/24/2015)... NexID Biometrics LLC, whose spoof-mitigation technology boosts protection ... beginning of shipments of version 2.0 of its industry ... in Potsdam, N.Y. , is making ... here today at the Walter E. Washington Convention Center. ... boosts the accuracy rate range to 96.5 to 99.5 ...
(Date:3/23/2015)... ANGELES , March 23, 2015  In the ... Federal fraud case conviction losses. This figure accounts for ... which, according to The Nilson Report, exceeds $11 billion ... investigative tool after a crime has occurred. Investor ... and polygraph expert Joe Paolella partnered to ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... the United States should be cautious but not overly ... director at Kansas State University. Gary Anderson, director ... of the virus, which recently cropped up in the ... in the United States. "We are fortunate that ...
... School of Medicine of the University of Southern California ... & Eileen L. Norris Foundation that will be critical in ... the study of epigenetics. The grant will solidify USCs ... great promise in the treatment and prevention of cancer, says ...
... An idea Rochester Institute of Technology professor James Winebrake ... energy issues at Shenandoah National Park in Virginia has ... national parks to identify ways to make historic sites ... Winebrake recently won a $350,000 grant from the National ...
Cached Biology News:K-State Veterinary Lab routinely tests for bluetongue virus 2$10 million gift to support cutting-edge epigenome center at USC 2$10 million gift to support cutting-edge epigenome center at USC 3Universities partner with national parks to give historic sites energy makeovers 2
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Sheep polyclonal to Melatonin ( Abpromise for all tested applications). Antigen: Melatonin Tg conjugate....
Goat anti-PITPN Class: Antibody Product Group: Miscellaneous Antibody...
COMING SOON: Anti-Mouse CD205 (DEC-205),Clone NLDC-145, mAb...
Biology Products: